Doctor of Dentistry Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Douglas Heller

Dentist, Periodontics Aurora, CO Doctor of Dentistry

NPI 1043288947 CMS profile 273536

2900 S Peoria St, Building D, Aurora, CO 80014

Open in the dashboard

General payments

$15,741

93 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Douglas Heller of Aurora, CO is reported in the CMS Open Payments database as having received $15,741 across 93 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 95th percentile of Dentist, Periodontics profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,182 8
2024 General $6,276 15
2023 General $2,398 21
2022 General $156 6
2021 General $463 10
2020 General $2,819 20
2019 General $448 13

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Douglas Heller
  • Dentist, Periodontics median
  • Middle half of Dentist, Periodontics
  • National median

In program year 2025, general payments to Douglas Heller were reported at $3,182. Among 2,732 Dentist, Periodontics profiles paid that year, the median was $112 and the middle half received between $42 and $307.

Show as a table
Year Douglas Heller Dentist, Periodontics median Middle half National median
2019 $448 $129 $42–$367 $163
2020 $2,819 $90 $35–$265 $114
2021 $463 $125 $42–$411 $132
2022 $156 $123 $43–$364 $149
2023 $2,398 $125 $45–$358 $160
2024 $6,276 $119 $42–$350 $164
2025 $3,182 $112 $42–$307 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Straumann USA LLC $12,131 36 payments
  2. Keystone Dental Inc. $1,521 2 payments
  3. Dentsply Sirona Inc $1,282 33 payments
  4. Geistlich Pharma, North America, Inc. $157 2 payments
  5. Align Technology, Inc. $126 3 payments
  6. Zimmer Biomet Holdings, Inc. $110 3 payments
  7. Nobel Biocare USA $88 2 payments
  8. Celgene Corporation $78 1 payment
  9. Southern Implants North America Inc $76 3 payments
  10. DENTSPLY IH Inc. $50 2 payments
  11. Other $122 6 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $8,700 3 payments
  2. Gift $2,765 16 payments
  3. Food and Beverage $2,255 69 payments
  4. Education $1,596 3 payments
  5. Travel and Lodging $425 2 payments
Products named General payments · program years 2019–2025
  1. ASTRA TECH Implant System Implant Dentistry $544 18 payments
  2. Implant Dentistry $453 3 payments
  3. ASTRA TECH Implant System Implant Dentistry $202 6 payments
  4. Geistlich Bio-Gide $140 1 payment
  5. Invisalign $126 3 payments
  6. REBLOZYL $78 1 payment
  7. TSV NG Surgical $75 1 payment
  8. NOBELACTIVE $63 1 payment
  9. NOBELPARALLEL $63 1 payment
  10. ATLANTIS $49 2 payments
  11. Other $356 18 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

322

Median for Dentist: 47

Drug cost

$2,120

Median for Dentist: $159

Branded share of claims

0%

Median for Dentist: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Etodolac Generic 104 $1,041
Amoxicillin Generic 172 $841
Metronidazole Generic 13 $91
Azithromycin Generic 14 $76
Triazolam Generic 19 $72

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 110,731 Part D prescribers listed as Dentist; they describe a distribution and say nothing about conduct.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
REBLOZYL
  • Celgene Corporation $78
$78 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

93 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Dentist, Periodontics in Colorado

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record